Diversified Growth Company - Swiss Excellence Class A CHFRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 10.7 | 20.5 | -11.7 | 13.2 | 1.9 | |
+/-Cat | 0.3 | 0.5 | -3.0 | 2.3 | 1.8 | |
+/-B’mrk | - | -1.8 | -4.5 | 4.6 | 2.0 | |
Category: Switzerland Equity | ||||||
Category Benchmark: Morningstar Switzerland TME... |
Key Stats | ||
NAV 23/04/2024 | CHF 145.57 | |
Day Change | 0.47% | |
Morningstar Category™ | Switzerland Equity | |
ISIN | LU1479929470 | |
Fund Size (Mil) 22/04/2024 | CHF 46.14 | |
Share Class Size (Mil) 22/04/2024 | CHF 33.68 | |
Max Initial Charge | - | |
Ongoing Charge 12/04/2024 | 1.77% |
Investment Objective: Diversified Growth Company - Swiss Excellence Class A CHF |
The investment objective of the Sub-Fund is to achieve a better performance in the Swiss equity market than a benchmark made up of 65% of the Swiss Leader Index Total Return (SLIC) and 35% of the Swiss Leader Index (SLI) by investing mainly in Swiss shares, certificates of shares and equity-like transferable securities. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Marie Fonta 01/01/2019 | ||
Inception Date 02/01/2017 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
65% SLIC Swiss Leaders TR CHF , 35% SIX SLI Swiss Leaders TR CHF | Morningstar Switzerland TME NR CHF |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Diversified Growth Company - Swiss Excellence Class A CHF | 31/05/2023 |
|
|
Top 5 Holdings | Sector | % |
Novartis AG Registered Shares | Healthcare | 8.39 |
Roche Holding AG | Healthcare | 7.62 |
Nestle SA | Consumer Defensive | 7.61 |
Compagnie Financiere Richemont S... | Consumer Cyclical | 5.36 |
Holcim Ltd | Basic Materials | 4.28 |
Increase Decrease New since last portfolio | ||
Diversified Growth Company - Swiss Excellence Class A CHF |